A recent memorandum from the Department of Science and Technology suggested incentivizing publications and patents by doctoral research scholars through a monetary reward scheme. In this opinion article, Shambhavi Naik, Takshashila Institution, and Megha, National Centre for Biological Sciences (NCBS), discuss the implications and possible repercussions of such a policy.
Aravindhan Vivekanandhan is an Assistant Professor at the Department of Genetics, University of Madras. In this opinion piece, he discusses the damaging consequences that may result when analogies turn into claims and pseudoscientific statements are put forward in national scientific forums.
When it comes to attracting and retaining quality post-doctoral fellows, India often finds itself lagging behind, which in turn exerts a cost on the scientific output of the country. In this opinion piece, Shambhavi Naik, Research Fellow, Technology and Policy Programme, Takshashila Institution, and Megha, India Alliance Early Career Fellow at the National Centre for Biological Sciences (NCBS), examine possible causes and suggest solutions to this issue.
The month of March saw a landmark decision by an Indian Court, wherein it granted compulsory license to an Indian pharmaceutical – NATCO to manufacture generic version of the drug Nexavar thereby breaking Bayor’s monoplogy on this life saving drug for Hepatocarcinoma.